UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Greenhouse Solutions Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

39530T103

(CUSIP Number)

Dr. Malireddy S. Reddy
c/o ADFAC/IMAC
1250 S. Parker Road, Suite 203
Denver, CO 80231
303-944-5215

(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)

January 21, 2015

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: ____


SCHEDULE 13D

1. NAME OF REPORTING PERSON

Dr. Malireddy S. Reddy

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
a. ___
b. ___

3. SEC USE ONLY

4. SOURCE OF FUNDS

PF

5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) ______

6. CITIZENSHIP OR PLACE OF ORGANIZATION

USA

7. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

SOLE VOTING POWER

7,000,000

8. SHARED VOTING POWER

0

9. SOLE DISPOSITIVE POWER

7,000,000

10. SHARED DISPOSITIVE POWER

11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

7,000,000

12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES _____

13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

7.8%

14. TYPE OF REPORTING PERSON

IN

ITEM 1. SECURITY AND ISSUER

This statement on Schedule 13D ("Schedule 13D") is being filed with respect to the common stock, $0.0001 par value (the "common Stock"), of Greenhouse Solutions Inc., a Nevada corporation (the "Company"). The Company's principal executive office is located at 8400 E. Crescent Parkway, Suite 600, Greenwood Village, Colorado 80111.

2

ITEM 2. IDENTITY AND BACKGROUND

(a) This statement is filed by Dr. Malireddy S. Reddy (the "Reporting Person") with respect to shares directly owned by him.

Any disclosures herein with respect to persons other than the Reporting Person is made on information and belief after making inquiry to the appropriate party.

(b) The business address of Dr. Malireddy S. Reddy is c/o ADFAC/IMPAC, 1250 S. Parker Road, Suite 203, Denver, CO 80231.

(c) The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(d) The Reporting Person has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

On January 21, 2015, the Reporting Person acquired 7,000,000 shares of the Company's voting Common Stock issued for a License for certain IP owned by Reporting Person.

ITEM 4. PURPOSE OF TRANSACTION

The shares of Common Stock owned by the Reporting Person were acquired for, and are being held for, investment purposes. As discussed above, the shares were acquired pursuant to a License granted by Reporting Person.

The Reporting Person may in the future directly acquire shares of Common Stock in open market or private transactions, block purchases or otherwise. The Reporting Person may continue to hold or dispose of all or some of the securities reported herein from time to time, in each case in open market or private transactions, block sales or purchases or otherwise, subject to compliance with applicable law. Other than as set forth herein, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (b) through (j), inclusive, of Item 4 of the Schedule 13D. The Reporting Person may, at any time and from time to time, review or reconsider his position and formulate plans or proposals with respect thereto, but has no present intention of doing so.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

(a) As of the close of business on January 21, 2015, the Reporting Person was the beneficial owner, within the meaning of Rule 13d-3 under the Exchange Act, of 7,000,000 shares of common Stock. As of January 21, 2015, these shares represented 7.8% of the voting power of the 88,760,000 total voting shares of the Company's capital stock outstanding as reported.

(b) The sole or shared power to vote or dispose of, or to direct the vote or disposition of the Common Stock with respect to each Reporting Person noted in paragraph (a) of this Item 5 is as set forth on the cover sheets of this Schedule 13D.

(c) There have been no transactions involving the shares of Common Stock of the Company engaged in during the 60 day period prior to and including January 21, 2015, up to the present.

3

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER

There are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting person named in Item 2 of this statement and between such Reporting Person and any person with respect to any securities of the Company, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

A new business direction is being pursued with new management and with equity participation by new principals. The CEO/Director, Rik Dietsch, has acquired 4,000,000 shares of Common Stock (4.51%) for a Sub-License of certain proprietary formulations related to CBD Oil and as may be legally allowed, marijuana products. The President/Director, Redgie Green, has purchased 200,000 shares of Common Stock (0.23%), and Director, John G. Michak, III, has purchased 29,000,000 shares of common Stock (32.7%) from George Dory. Mr. Dory returned 11,000,000 shares of stock to treasury. There is an understanding that the license and Sub-License provided to the Company by Dr. Reddy and Mr. Dietsch respectively are conditioned on performance thereunder. Dr. Reddy received 7,000,000 shares as consideration for a License of probiotic formulas for CBD Oil and marijuana products if legal.

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS

Exhibit 10.1 License Agreement Between Dr. M.S. Reddy and Greenhouse Solutions, Inc.

4

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, correct.

/s/ Malireddy S. Reddy
---------------------------------------------
Dr. Malireddy S. Reddy

5